Atorvastatin Oxirane Impurity is a chemical compound identified as a process-related byproduct in the synthesis of atorvastatin, a statin medication. It is defined by an oxirane ring structure containing a fluorobenzoyl and diphenylcarboxamide group, and is primarily used as a reference standard in pharmaceutical quality control and research.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1246818-88-1
2-((5-Bromopyrimidin-2-yl)oxy)ethan-1-ol
n.a
5,6-Dihydroxy-2,3-dihydro-1H-inden-1-one
n.a
N-[(E)-1-cyclohexa-2,4-dien-1-yl-3-phenylprop-2-enylidene]-4-[2,5-di(carbazol-9-yl)carbazol-9-yl]-3,5-diphenylbenzenecarboximidamide
n.a
2-Ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine
n.a
3-((4-Fluorophenyl)carbonyl)-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide
atorvastatin impurity reference standard
3-(4-fluorobenzoyl)-2-(2-methylpropyl)-N,3-diphenyloxirane-2-carboxamide
WTTRRISNQAPVTN-UHFFFAOYSA-N
CC(C)CC1(C(O1)(C2=CC=CC=C2)C(=O)C3=CC=C(C=C3)F)C(=O)NC4=CC=CC=C4